Waters Posts $1.767 Billion Q3 Revenue, Lifts 2026 Outlook

Waters (NYSE:WAT) booked third-quarter 2026 revenue of $1.767 billion, $14 million above its own guidance midpoint, with organic sales up 9% year on year. The beat came with a sharp divergence between two earnings figures: adjusted earnings per share rose 21% to $4.10 from $3.40, while GAAP diluted earnings collapsed to $0.82 from $2.50 in the prior-year quarter.

The company also raised its full-year 2026 guidance and disclosed the completed acquisition of MOBILion Systems, a deal intended to expand its protein-analysis technology. Each promise in the release carries a caveat, and the GAAP number is the largest one.

Where the revenue actually came from

Reported growth splits unevenly. Organic revenue reached $871 million, while acquired businesses contributed $896 million — slightly more than half of the quarter's total. That composition matters. Nearly half of the reported top line did not exist in the prior year on the same basis, which means the 9% organic growth rate, not the headline figure, is the number that measures underlying demand.

Within the portfolio, Analytical Sciences revenue increased 8% to $703 million. The release does not break out performance beyond that segment, and it does not say how much of the acquired revenue came from MOBILion versus earlier deals. In plain words: organic demand is real, but acquisitions now drive roughly half the reported top line.

Why GAAP earnings fell while adjusted earnings rose

The gap between $4.10 and $0.82 comes from acquisition-related charges and restructuring costs, which weighed on reported earnings. The release quantifies neither the charges nor the restructuring outlays, and it does not state when those costs will taper. Adjusted earnings beat the analyst consensus of $4.00 by ten cents.

CFO readers should treat the 21% adjusted growth as a management-defined figure until the filing discloses the size of the adjustments. The one-sentence takeaway: the company earned far less under accounting rules than under its own adjusted definition, and the difference is acquisition-related.

What did guidance actually move to?

Waters raised its 2026 revenue forecast to a range of $6.479 billion to $6.497 billion. It lifted adjusted earnings guidance to $14.60 to $14.70 per share. Both ranges are narrow — under $20 million wide on revenue and ten cents wide on earnings — which signals management confidence in forecast precision but leaves little room for error in the final quarter.

For the fourth quarter, the company guided to:

• Revenue of $1.801 billion to $1.819 billion
• Adjusted earnings of $4.58 to $4.68 per share

The release did not provide GAAP earnings guidance, nor did it quantify the expected ongoing drag from integration costs. That omission leaves the full accounting picture for the year unresolved.

What does the MOBILion acquisition change?

Waters completed its acquisition of MOBILion Systems during the quarter to expand its protein-analysis technology. The company disclosed no purchase price, no revenue contribution, and no closing date in the release. The deal sits behind the $896 million acquired-revenue line, but its individual weight within that figure remains unstated.

The strategic direction is legible: proteomics and protein analysis extend the instrument franchise into adjacent analytical markets. Whether the price justified the capability is a question the release does not answer.

The bottom line

Waters beat its midpoint, grew organically at 9%, and raised full-year guidance — yet GAAP earnings fell 67% while adjusted earnings rose 21%, and the acquisition costs driving that gap remain unquantified. The raised outlook is credible on organic trends and unproven on reported profit.